At this beautiful moment of bidding farewell to the old and welcoming the new,
we look back on the journey of the past year,
and our hearts are full of fruitful results and harvests.
Every unremitting effort,
every innovative achievement,
are like bright pearls,
embedded in the long river of corporate growth,
guiding us to continue to climb new paths.
· Practice Responsibility
Participate in the formulation of the national standard plan

02
Donate to Zhejiang University Education Foundation,
support national scientific research construction
·Technology Innovation
01
Continue to Deepen the Exploration of Core Technologies
The perfect combination of natural power and modern technology is our unwavering pursuit. In order to ensure the precise release of active ingredients, the company independently developed BioProdEx® self-assembling nano-microcapsule technology, which can almost achieve full protection of the target ingredients, thereby revolutionizing the utilization rate of active ingredients.
The self-developed DIMT™ digital decoction technology is a combination of advanced DSC platform to innovate traditional decoction technology, solving problems such as difficult quality control, difficult process data traceability and poor batch stability. The upgrading of this series of technologies has broadened the application areas of products, reduced production costs, shortened production cycles, and improved product quality.

Comprehensively build an intellectual property strategy system
In 2024, we added 10 invention patents, which cover multiple fields from plant extraction technology to nutritional formulas, adding new highlights to our technological advantages. So far, our company has a total of 114 patents.


Keyword of the Year NO.3
·Breaking the Boundary
01
Second-generation probiotics, silk protein microneedle project

In August, Taiyi Health and Guangzhou Zhiyi Biotechnology Co., Ltd. jointly established the "Guangdong Province Live Biopharmaceutical Engineering Technology Research Center-Second-generation Probiotics Innovative Food Collaborative R&D Center", opening a new chapter of strong cooperation and win-win development between the two companies. In December, AKK AM06™ was certified by the United States GRAS, and Taiyi Health became the world's only exclusive distributor of AKK AM06™ strains.
In October, the Silk Protein Biotechnology Application Research Institute was established. The main research direction of the institute is the application of natural silk and functional fibers in the repair of defective tissues such as skin, blood vessels, and nerves, as well as medical devices and innovative preparations. It breaks through the common bottleneck problems in the current application of functional silk, and incubates industrial projects with market potential around the pilot technology verification platform to complete the transformation and upgrading of the traditional silk industry.
·Quality and Efficiency Upgrade
Zebrafish Efficacy Experimental Platform

Officially put into use
At present, we have introduced 7 mature model systems and established rapid screening methods for raw materials and finished products, so as to more efficiently assist R&D in formula screening, product optimization and other matters, and provide customers with products that meet market expectations.
·Quality Traceability
01
Qingyunshan Factory Traceability Tour

·Moment of Glory
Oral instant powder technology, BioProdEx® self-assembled nano-microcapsule technology, and DIMTTM digital decoction technology have also been highly recognized by international invention organizations such as the United States and Poland.
This series of honors is not only a great affirmation of the product's technical level and R&D capabilities, but also a powerful testimony to the trust and recognition of our product quality and services.


